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Patients with organ failure often suffer from increased morbidity and
decreased quality of life. Current strategies of treating organ failure have
limitations, including shortage of donor organs, low efficiency of grafts,
and immunological problems. Tissue engineering emerged about two dec-
ades ago as a strategy to restore organ function with a living, functional
engineered substitute. However, the ability to engineer a functional organ
is limited by a limited understanding of the interactions between materials
and cells that are required to yield functional tissue equivalents. Poly-
meric materials are one of the most promising classes of materials for use
in tissue engineering, due to their biodegradability, flexibility in process-
ing and property design, and the potential to use polymer properties to
control cell function. Stem cells offer potential in tissue engineering
because of their unique capacity to self-renew and differentiate into neu-
rogenic, osteogenic, chondrogenic, and myogenic lineages under appro-
priate stimuli from extracellular components. This review examines
recent advances in stem cell–polymer interactions for tissue regenera-
tion, specifically highlighting control of polymer properties to direct adhe-
sion, proliferation, and differentiation of stem cells, and how biomaterials
can be designed to provide some of the stimuli to cells that the natural
extracellular matrix does. Birth Defects Research (Part C) 96:63–
81, 2012. VC 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Failure of organ function due to
injury, disease, or aging accounts
for a significant number of clinical
disorders at a tremendous social
and economic cost (Freed et al.,
2009). In the United States,
nearly 6 million bone fractures
occur each year (Zhao et al.,
2010), and worldwide, 8 million
persons suffer a myocardial infarc-
tion (Kraehenbuehl et al., 2008).
The failure of organs also has a
significant impact on quality of
life. For example, patients with
traumatic spinal cord injury often
suffer lifetime sensory and motor
deficits below the site of injury
(Hsieh et al., 2010).
Current treatments for organ fail-
ure vary with the type of organ
affected, but all have limitations.
For cardiac functional failure, one
of the current strategies is to
deliver functional cells to the myo-
cardium. However, this strategy
results in low engraftment effi-
ciency and cell viability in infracted
hearts (Ye et al., 2011). Cardiac
transplantation can significantly
lengthen and improve quality of
life. It is limited, however, due to a
chronic shortage of donor hearts
(Leor et al., 2000). With the
replacement of diseased or dam-
aged bone, autologous bone grafts
are preferable because they contain
the patient’s own cells and proteins,
which not only provide a framework
for new bone to grow into, but also
are immunogenetically compatible.
Despite satisfying clinical results,
autografts often lead to morbidity
at the surgical site. Another strat-
egy is to use an allogenic bone
graft. However, utilization of these
grafts carries the risk of immuno-
logical rejection or disease transfer
(Cordonnier et al., 2011).
To overcome these limitations in
organ transplantation and graft-
ing, the field of tissue engineering
emerged about two decades ago.
Tissue engineering combines the
disciplines of both the materials
sciences and the life sciences to
replace a diseased or damaged tis-
sue or organ with a living, func-
tional engineered substitute (Chan
and Mooney, 2008; Marklein and
Burdick, 2010). However, tissues
such as bone, articular cartilage,
and myocardium possess highly
specialized structures and compo-
sitions that provide unique me-
chanical and transport properties
(Freed et al., 2009). Therefore, to
reconstruct a functional engineered
tissue substitute, it is necessary to
understand how these specialized
structures and compositions affect
cell behavior in vivo, and use this
information to direct the design of
substitute tissues and organs.
Unfortunately, our ability to design
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a functional organ substitute is lim-
ited by an incomplete understand-
ing of the interactions between
materials and cells, and an inability
to control the complex signaling
pathways elicited by these interac-
tions (Fisher et al., 2010).
The first question that needs to
be answered, to optimize any tis-
sue engineering strategy geared
toward producing a functional tis-
sue equivalent, is what cell type
and substrate material are appro-
priate for the particular tissue en-
gineering goal at hand. Stem cells
and polymeric materials are key
design choices due to their unique
properties. Briefly, stem cells have
the ability to self-renew and commit
to specific cell lineages under appro-
priate stimuli. Polymeric materials
are biocompatible, degradable, and
flexible in processing and property
design. A significant focus of tissue
engineering, therefore, is to utilize
polymers, or soft materials, as a
means of controlling stem cell func-
tion via physical, chemical, mechani-
cal, and/or biological cues ‘‘commu-
nicated’’ to from the polymer to the
cells.
This review examines recent
progress in stem cell–polymer inter-
actions for tissue regeneration. Spe-
cifically, we focus on how polymer
material properties affect the activ-
ity of stem cells in vitro and further
tissue regeneration in vivo. The
design of novel polymeric biomateri-
als with appropriate physical, chemi-
cal, mechanical, and biological cues
to guide stem cell adhesion, prolifer-
ation, and differentiation are dis-
cussed. Finally, we discuss how the
ability of a biomaterial to guide stem
cell function can lead to improved
outcomes for nerve, bone, cartilage,
and cardiac regeneration.
Characteristics of
Stem Cells
Stem cells are an important cell
type for cell-based therapy and
regenerative medicine, especially
within the rapidly expanding field
of tissue engineering, due to their
two unique properties, self-
renewal and differentiation. With
the first unique property, these
cells can be easily expanded in vitro
and, therefore, a large cell number
can be obtained for seeding onto
three-dimensional (3D) scaffolds of
clinically relevant volume and sub-
sequent cell transplantation. Stem
cells can also give rise to more
committed cell types, such as
osteoblasts, chondrocytes, adipo-
cytes, and neuronal cells, when
they receive the appropriate cues.
Based on their differentiation
potential, stem cells used for tis-
sue engineering can be divided
into two categories, pluripotent
stem cells and multipotent stem
cells. Pluripotent stem cells include
embryonic stem cells (ESC) and
induced pluripotent stem cells
(iPSC). Compared to multipotent
stem cells, pluripotent cells can
self-renew indefinitely. Their
pluripotent nature gives them the
ability to differentiate into any one
of the three germ layers: endo-
derm, ectoderm, and mesoderm
(Dawson et al., 2008). Because
ESCs are isolated from the inner
cell mass of the blastocyst during
embryological development, their
use in tissue engineering is contro-
versial and more limited. Although
iPSCs are obtained by genetically
modifying somatic cells, more
attention has been paid to this cell
type recently. Examples of multi-
potent stem cells include bone
marrow derived-mesenchymal
stem cells (MSCs), hematopoietic
stem cells, neural stem cells
(NSCs), and adipose derived stem
cells (ASCs). These stem cells
exist in the corresponding differ-
entiated tissues, renew them-
selves for the lifetime of the orga-
nism, and yield all of the special-
ized cell types of the tissue from
which they are originated.
Factors Controlling
Stem Cell Behavior
Maintaining stem cells in an un-
differentiated state and subse-
quently directing them to differen-
tiate in a reliable and reproducible
manner into specific cell types are
key issues in stem cell biology
(Dawson et al., 2008) and conse-
quently in stem cell-based tissue
engineering. Cell adhesion, prolif-
eration, and differentiation are
largely dictated by signals from
extracellular components, such as
soluble biological and pharmaco-
logical factors in fluid, extracellular
matrix (ECM), and other adjacent
cells (cell–cell crosstalk; Fig. 1). It
has been long recognized that not
only the type, but also the dose,
spatial and temporal distribution
of soluble factors play an impor-
tant role in mediating cell behavior
(Luong et al., 2006; Beohar et al.,
2010; Zhang et al., 2010b).
Various properties of the ECM
influence cell adhesion, prolifera-
tion, and differentiation, including
physical properties (roughness,
stiffness, surface patterning, and
electrical conductivity), chemical
properties (concentration of mono-
mers and functional groups), as
well as structural properties (cross-
linking, morphology, 2D vs. 3D)
(Murphy et al., 2005). Cell–cell
communication is also critical to
cell differentiation. For example,
enhancement of gap junction inter-
cellular communication leads to an
increasedmagnitude and spatial dis-
tribution of differentiation markers
and consequently an increased vol-
ume fraction and spatial uniformity
of in vivo (Rossello et al., 2009).
Individual factors, as well as combi-
nations of factors from the extracel-
lular environment, affect cell adhe-
sion, viability, proliferation, and dif-
ferentiation (Chan and Mooney,
2008; Dawson et al., 2008). There-
fore, a key to advancing tissue engi-
neering is the ability to control the
signaling of multiple factors simulta-
neously.
Polymeric Materials
for Tissue Repair and
Regeneration
Polymeric materials for tissue
regeneration are of both natural
and synthetic origin (Table 1).
Examples of natural polymers
include collagen, fibrin, and poly-
saccharides, such as hyaluronic
acid and alginate. Natural polymers
contain a variety of biological cues,
including cell adhesion sequences,
and therefore, can be recognized by
cells. However, natural polymers
are subjected to batch-to-batch
variation due to the complexity of
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their structure and chemical com-
position, leading to variations in tis-
sue engineering outcomes. Com-
pared to natural polymers, syn-
thetic polymers can be more easily
synthesized on a large scale with
more precisely controlled molecular
weight and addition of functional
groups. However, synthetic poly-
mers in their native state can only
support cell adhesion and growth to
a limited extent since they lack
functional groups for cell interaction
(Alvarez-Barreto et al., 2011). The
synthetic polymers that have
Figure 1. Factors controlling stem cell behavior arise from their interactions with growth factors, ECM, and niche cells (Schematic
diagram is modified from ‘‘D. E. Discher, et al. (2009). Growth factors, matrices, and forces combine and control stem cells. Science
324, 1673’’; copyright 2009, with permission from The American Association for the Advancement of Science).
TABLE 1. Major Polymeric Materials for Tissue Regeneration
Polymer name Main applications and properties References
Natural polymers
Alginate Bone, nerve, and cartilage regeneration;
enzymatically degradable
Banerjee et al. (2009),
Shanbhag
et al. (2010)
Collagen Bone, heart and cartilage regeneration;
enzymatically degradable
Battista et al. (2005)
Hyaluronic acid Cartilage, nerve regeneration;
degradable
Tian et al. (2005), Ren
et al., (2009), Park
et al. (2010)
Chitosan Cartilage regeneration; degradable Chung et al. (2011)
Fibrin Cartilage regeneration; degradable,
injectable
Ahearne et al. (2011)
Synthetic polymers
Poly(vinyl alcohol) Cartilage regeneration; nondegradable Spiller et al. (2011)
Poly(hydroxyethyl methacrylate) Cartilage regeneration; nondegradable Singh et al. (2011)
Poly(N-isopropylacrylamide) Cartilage regeneration; nondegradable Sa-Lima et al. (2011)
Polyethylene terephthalate Bone regeneration; nondegradable Cao et al. (2010)
PGA Cartilage regeneration; bulk degradable Bilir et al. (2011)
Poly(lactic acid) PLA Cartilage, nerve, bone regeneration;
degradable
Yang et al. (2005)
Liao et al. (2011)
Polyethylene oxide Cartilage regeneration; injectable,
degradable
Akpalo et al. (2011)
PLGA Bone, nerve regeneration; bulk
degradable
Levenberg et al. (2003)
Poly caprolactone Bone, nerve regeneration; degradable Mahairaki et al. (2011)
Polypyrrole (PPy) Nerve regeneration; conductive polymer Lundin et al. (2011)
Poly (propylene fumarte) Bone regeneration; bulk degradable,
injectable
Shin et al. (2011)
Polyanhydrides Bone regeneration, surface degradable Li et al. (2004)
Aminopropylmethacrylamide (APMAAm) Support self renewal of human
embryonic stem cell
Irwin et al. (2011)
Poly(methyl vinyl
ether-alt-maleic anhydride)
Support self renewal of human
embryonic stem cell
Brafman et al. (2010)
PEG Heart, bone regeneration; degradable Kraehenbuehl et al.
(2008)
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received the most study are poly
(L-lactic acid) (PLLA), poly(glycolic
acid) (PGA), poly(lactic-co-glycolic
acid) (PLGA), poly(ethylene glycol)
(PEG), polycaprolactones, poly-
orthoesters, polyanhydrides, and
polycarbonates (Chan and Mooney,
2008).
There are at least two advantages
of using polymeric materials for tis-
sue regeneration. First, the struc-
ture and composition of polymers
can be easily tailored to yield a
variety of physical and chemical
properties that can elicit certain
cellular functions, including prolifer-
ation and differentiation in a con-
trolled manner. Second, many of
the polymers are biodegradable
through either hydrolysis or via
activities of enzymes secreted by
cells. Therefore, over a prescribed
time, the scaffold can be replaced
by newly formed tissue. Thus, with
degrading polymers, a secondary
surgery is not needed to remove
the scaffold after implantation.
A drawback of many polymers,
however, is that their biocompati-
bility is lower than other types of
biomaterials, such as ceramic
materials. Polymeric materials are
usually encapsulated by a persis-
tent layer of fibroblasts, collagen,
and inflammatory cells in vivo,
which is suboptimal for tissue for-
mation (Vergroesen et al., 2011).
However, the biocompatibility of
polymer materials can be improved
by engineering functionality into
these materials. The behavior of
stem cells can be controlled by
engineering functionality into a bio-
material, such as via immobiliza-
tion of adhesion peptides, modifi-
cation of surface chemistry, and
mineralizing polymer surfaces.
CELL ADHESION AND
PROLIFERATION ON
POLYMERIC MATERIALS
2D Polymeric Substrates
2D polymeric substrates have
been used for in vitro cell culture
for decades, and surface proper-
ties of roughness and topography
can be more easily and precisely
controlled over a 2D surface than a
3D scaffold (Naing and Williams,
2011). A well-defined surface can
subsequently benefit the study of
the interactions between cells and
materials, decrease variability in
cell response, and lead to less com-
plication in the interpretation of
data. Effects of surface properties,
such as stiffness and topography,
on cell adhesion and proliferation
have been extensively investigated
(Castellani et al., 1999; Discher
et al., 2005; Saha et al., 2008).
The magnitude of surface stiff-
ness affects cell adhesion and pro-
liferation (Pek et al., 2010; Wang
et al., 2010a; Chandler et al.,
2011; Park et al., 2011a; Schrader
et al., 2011). For example, 2D poly-
mer substrates with moduli greater
than 1000 Pa favor proliferation of
adult NSCs, whereas cell spreading
and proliferation are inhibited on
substrata with moduli of 10 Pa
(Saha et al., 2008). The trend of
stiffer surfaces leading to a higher
rate of proliferation holds for many
other cell types, such as adipose
progenitor cells, human MSCs, and
hepatocellular carcinoma cells
(Wang et al., 2010a; Chandler
et al., 2011; Park et al., 2011a;
Schrader et al., 2011).
Besides surface stiffness, sur-
face topography is another impor-
tant factor that controls cell adhe-
sion and proliferation. Various fab-
rication methods are used to alter
surface topography or create
microscale and nanoscale features
to facilitate cell adhesion (Castel-
lani et al., 1999; Hatano et al.,
1999; Deligianni et al., 2001;
Anselme et al., 2002; Korovessis
et al., 2002; Linez-Bataillon et al.,
2002; Zhao et al., 2006b). Surfa-
ces with lower periodicity (e.g.,
totally random surface) generally
favor cell adhesion and prolifera-
tion (Anselme et al., 2000; Biger-
elle and Iost, 2001). However,
most studies only focus on cell
responses to static surface topog-
raphy or patterning. One interest-
ing study designed a dynamic sub-
strate that can communicate
active physical cues to cells
(Le et al., 2011). In this study, the
surface of thermally responsive
poly(e-caprolactone) shape-memory
polymers transformed between a
3 3 5 lm2 channel array and a pla-
nar surface at 378C. Correspond-
ingly, the morphology of hMSCs
switched from highly aligned to
stellate shaped. Meanwhile, cell
attachment and detachment can be
controlled by thermally responsive
polymer substrates (Hatakeyama
et al., 2005; Idota et al., 2009;
Kumashiro et al., 2010). The
detachment of cells from such tem-
perature-responsive surfaces is
achieved by lowering the tempera-
ture without conventional enzy-
matic treatment, while keeping the
deposited ECM intact (Kumashiro
et al., 2010).
Two-dimensional polymeric
surfaces have been investigated
for supporting self-renewal of plu-
ripotent stem cells, including ESCs
and iPSCs (Brafman et al., 2010;
Villa-Diaz et al., 2010; Irwin et al.,
2011). The successful integration
of stem cells into tissue engineer-
ing requires large-scale cell
expansion without differentiation.
Therefore, the precise control the
self-renewal of stem cells is impor-
tant (Irwin et al., 2011).
The motivation for using a 2D
polymeric substrate to support
self-renewal of pluripotent stem
cells is the lack of chemically
defined culture system for these
cells. Pluripotent stem cells are
typically maintained on a feeder
layer of mouse cells with a combi-
nation of the animal-based prod-
ucts, which are expensive, difficult
to isolate, subject to batch-to-
batch variations, and unsuitable
for translation cell-based therapies
to the clinic (Brafman et al.,
2010). Therefore, a defined sys-
tem is needed for better supporting
hESC self-renewal. The first
attempt to create a fully defined
synthetic polymer coating to sup-
port hESC self-renewal was done
by Villa-Diaz et al. (2010), where
poly[2-(methacryloyloxy)ethyl di-
methyl-(3-sulfopropyl)ammonium
hydroxide] (PMEDSAH) was
created by UV-ozone activated
polymerization. Cells seeded on
PMEDSAH expressed characteristic
hESC markers, displayed a normal
karyotype and retained pluripo-
tency throughout 25 passages. In
this study, however, only human
ESCs were evaluated. Just a few
months later, a new polymeric sub-
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strate, poly(methyl vinylether-alt-
maleic anhydride), that can support
both hESC and iPSC self-renewal,
was identified through a high-
throughput screening approach
(Brafman et al., 2010). Both cell
types exhibited their characteristic
morphology and grew as tightly
clustered colonies expressing pluri-
potency markers, such as OCT4,
NANOG, and SOX2 over five
passages.
A disadvantage of the techni-
ques described earlier is that se-
rum supplemented, chemically
undefined cell culture media is
used. In these media, fetal bovine
serum or similar serum is used to
provide growth factors for stem
cell adhesion and proliferation.
However, the type or concentra-
tion of individual growth factors
is not fully characterized and
often varies between batches.
Self-renewal of pluripotent cells
on polymeric substrates was
advanced by the development of a
complete chemically defined cell
culture system with serum-free
media (Irwin et al., 2011). In this
study, the pluripotency of hESCs
was maintained on aminopropyl-
methacrylamide (APMAAm) for
over 20 passages in chemically
defined mTeSRTM1 media. This
synthetic and defined cell culture
system does not require the prior
attachment of peptides or proteins
to promote cell attachment and is
free of complex, undefined culture
conditions.
The mechanisms explaining why
some polymeric substrates can
support self-renewal of pluripotent
stem cells are still not clear. It is
speculated that the hydrolysis
products of the polymers (e.g.,
carboxyl and sulfonyl groups) may
mimic functional features of pro-
teins that support self-renewal
(Brafman et al., 2010). An alter-
native hypothesis is that the exis-
tence of specific functional groups
on the polymer substrate either
stimulates the production of en-
dogenous proteins or promotes
the adsorption of exogenous pro-
teins that support self-renewal
(Brafman et al., 2010). Indeed,
bovine serum albumin in the
mTeSRTM1 media was identified
to be critical for cell adhesion and
potentially self-renewal of pluripo-
tent stem cells on APMAAm surfa-
ces (Irwin et al., 2011).
3D Scaffolds
Cells can behave differently in
2D and 3D systems. For instance,
tumor cells grown in 3D culture
are relatively more resistant to cy-
totoxic drugs compared with their
response in conventional 2D cul-
ture (Li et al., 2010). There has
been increasing agreement that
3D matrices provide better model
systems for physiologic situations
(Weaver et al., 1997; Zhao et al.,
2006a) such as enhanced cell–cell
contact or communications. Below,
we examine how the properties of
3D fibrous scaffolds, hydrogels,
and composites mediate cell adhe-
sion, viability, and proliferation.
Electrospun fibers of various nat-
ural polymers, including collagen
and fibrin, are used to fabricate 3D
scaffolds. Fiber diameter ranges
from 100 to 600 nm promote cell
adhesion and proliferation. (Kita-
zono et al., 2004; Bao et al., 2011;
Pant et al., 2011; Wei et al., 2011;
Wu et al., 2011). Compared to
microfibers, cells develop smaller
focal adhesion complexes and
exhibit higher proliferation on
nanofibers (Hsia et al., 2011).
Increasing the porosity and surface
area of fibrous scaffolds better
supports cell migration into the
scaffold, increasing the adhesion
and proliferation of cells (Rnjak-
Kovacina et al., 2011).
The orientation of the fibers can
also affect cell adhesion and viabil-
ity (Hsieh et al., 2010). For exam-
ple, a physical hydrogel blend of
hyaluronan and methylcellulose
incorporating electrospun fibers of
collagen or poly(3-caprolactone-
co-D,L-lactide) was developed to
promote cell–synthetic matrix
interactions and influence NSC
behavior. Although collagen scaf-
folds facilitate NSC transplantation
and help recovery of an injured
spinal cord (Hatami et al., 2009),
electronspun collagen fibers in
HAMC hydrogels inhibit NSC sur-
vival and proliferation. The fine,
fragmented, and tangled struc-
tures of the less oriented collagen
fibers are thought to be responsi-
ble for these inhibitory effects.
Indeed, human neural precursors
(NPs) on aligned polycaprolactone
fiber scaffolds exhibit a higher via-
bility than on randomly orientated
fibers (Mahairaki et al., 2011).
Human NPs seeded on aligned
fibers acquire a spindle-like shape
and extended processes parallel to
the fiber axis, whereas NPs on
plain tissue culture surfaces or
random fiber substrates form non-
polarized neurite networks
(Mahairaki et al., 2011). These
morphological differences are due
to the rearrangement of cytos-
keletal constituents, a process
that in turn can influence cell phe-
notype and function via estab-
lished links with intracellular
signaling pathways (Mahairaki
et al., 2011).
Hydrogels or polymers with high
water content ([99% water), are
another important class of 3D scaf-
folds. Hydrogels can be crosslinked
via chemical bonds, ionic interac-
tions, hydrogen bonds, hydropho-
bic interactions, or physical bonds,
and have been extensively studied
platforms because of their 3D na-
ture, biocompatibility, and versatil-
ity in processing (Tian et al., 2005;
Thonhoff et al., 2008; Banerjee
et al., 2009; Ren et al., 2009;
Hsieh et al., 2010; Shanbhag
et al., 2010). Hydrogels can be
synthesized by various methods,
such as radical polymerization, Mi-
chael addition chemistry, click
chemistry, and a variety of func-
tional moieties can be incorporated
to enhance biodegradability and
biocompatibility. Growth factors,
cytokines, and other chemical
additives can also be incorporated
into hydrogels to mediate cell ac-
tivity (Liu et al., 2010b).
Adhesion and proliferation of
stem cells can be influenced by
hydrogel properties, such as
hydrogel concentration and stiff-
ness. For example, human MSCs
shrink and degenerate on concen-
trated PF127 and PuraMatrix
hydrogels, and the viability of
human NSCs decreases as the
concentration of PF127 and Pura-
matrix increases (Thonhoff et al.,
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2008). The mechanism controlling
adhesion is unclear, but it is possi-
bly due to a complex dynamic
between cytotoxicity and growth
factor stimulation or the release of
harmful or acidic byproducts dur-
ing degradation of the hydrogel
(Thonhoff et al., 2008). Compared
to 2D surfaces, the stiffness of 3D
hydrogels affects cell proliferation
in a more complex way. Increasing
the hydrogel stiffness decreases
the proliferation of NSCs when
encapsulated in 3D alginate
hydrogels (Banerjee et al., 2009),
whereas hydrogels enhance cell
self-organization and subsequent
tissue development (Miyajima
et al., 2011). In contrast, smooth
muscle cell proliferation in 3D
PEG-conjugated fibrinogen hydro-
gels does not depend on gel stiff-
ness (Peyton et al., 2008).
Composite scaffolds offer biolog-
ical, chemical, and mechanical
advantages that go beyond what
each individual component can
provide. For example, the natural
polymer, fibronectin, is known for
its ability to promote cell adhe-
sion. Another natural polymer,
chitosan (CS), can promote differ-
entiation of stem cells to several
lineages. The combination of these
two polymers can offer a more
versatile scaffold for tissue regen-
eration (Chen et al., 2011; Chung
et al., 2011; Pei et al., 2011).
However, one problem that exists
in combining natural polymers is
that crosslinking molecules, which
are used to stabilize the construct,
often lead to in vivo complications,
including graft failure (Heydar-
khan-Hagvall et al., 2008).
Another type of composite is the
combination of two synthetic poly-
mers, for example, PLGA and poly-
acrylic acid (PAA), where PLGA is
biocompatible and degradable,
while PAA provides better adhe-
sive ability (Endres et al., 2003;
Cao et al., 2011). The hybridiza-
tion of synthetic and natural poly-
mers can also offer improved bio-
logical and mechanical properties
(Jiao et al., 2007; Craciunescu
et al., 2008; Heydarkhan-Hagvall
et al., 2008; Venugopal et al.,
2008; Liu et al., 2009; Liao et al.,
2010).
Incorporating polymeric and
inorganic materials is another way
to create composite materials with
superior mechanical and biological
properties. Inorganic components,
such as hydroxyapatite, can
improve protein adsorption and
subsequent cell adhesion (Leonova
et al., 2006; Zhao et al., 2006a;
Dimitrievska et al., 2008; Li et al.,
2009; Venugopal et al., 2010;
Akkouch et al., 2011). Mineralized
polymer surfaces can also be used
to provide sustained release of
growth factors and genes (Murphy
et al., 2000; Luong et al., 2006;
Luong et al., 2009; Segvich and
Kohn, 2009). Apatites and bioac-
tive glasses can also neutralize the
acidic byproducts of polymer deg-
radation, helping to maintain pH
within physiological ranges, sup-
porting cell function, and minimiz-
ing long-term adverse host
responses (Roether et al., 2002;
Yang et al., 2006; Zhao et al.,
2006a).
Surface Functionalization
As the first step in the sequence
of cell-biomaterial interactions,
initial adhesion of anchorage-
dependent cells is crucial to the
subsequent cell proliferation and
differentiation. Many methods
are used to physically modify bio-
material surfaces to increase cell
adhesion, including creating sur-
face roughness, topography, and
patterning (Vandrovcova and Baca-
kova, 2011). In general, nanostruc-
tured substrates with irregularities
smaller than 100 nm are more
favorable to cell adhesion and
growth than microstructured sub-
strates (Bacakova et al., 2011).
Trends in cell adhesion and prolifer-
ation with increased roughness
are inconsistent though (Zhang
et al., 2010b). Some literature
shows that optimal cell adhesion is
obtained with small roughness
ratios (Ranella et al., 2010), while
other literature shows opposite
results (Lohmann et al., 2000; Mar-
inucci et al., 2006; Zhao et al.,
2006b; Ponader et al., 2008). One
of the explanations for these con-
tradictory results is that various
methods (e.g., acid-etching vs.
sandblasting) used to create differ-
ent surface roughness ratios on
substrates changes surface reactiv-
ity or introduced new surface chem-
istry (Zhang et al., 2010b).
For polymeric materials, immo-
bilization of proteins, such as fi-
bronectin, laminin, and collagen,
or peptides, such as RGD and
YIGSR, on biomaterial surfaces
are the main chemical methods to
promote cell adhesion and prolifer-
ation (Cheng and Teoh, 2004;
Jeong et al., 2005; Shin et al.,
2008; Segvich et al., 2009a; Seg-
vich et al., 2009b). These mole-
cules can increase hydrophilicity
and surface charge, conditions
that facilitate integrin–adhesion
molecule interactions and are
favorable to cell adhesion. (Shin
et al., 2008; Pan et al., 2009;
Lundin et al., 2011). However, the
stability of these immobilized mol-
ecules is dependent on the bioma-
terial surface. As an example, the
anionic ions, tosylate (TsO), per-
chlorate (ClO4), and chloride (Cl),
doped on polypyrrole (PPy) de-
grade over time under physiologi-
cal conditions, resulting in low
NSC viability (Lundin et al., 2011).
Surface modification with layer-
by-layer assembly can enhance
cell adhesion (Boura et al., 2003;
D’Britto et al., 2009). The nature
of the substrate is largely deter-
mined by the characteristics of the
outmost layer. For example, bio-
active multilayer films composed
of PAA-b-PLGA and CS assembled
on the surface of PLLA films sup-
port better attachment and prolif-
eration of human adipose-derived
stem cells than PLLA films,
because of the more hydrophilic
PAA block chains (Cao et al.,
2011). Similarly, the interactions
of the RGD domain of FN and the
receptors on MSCs are responsible
for the higher cell mass on CNT/
CS/FN surfaces than on CNT/CS
and CNT/CS/HA surfaces (Chung
et al., 2011).
CONTROL OF CELL
DIFFERENTIATION ON
POLYMERS
Key components in the cellular
microenvironment that influence
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stem cell differentiation to more
committed lineages include soluble
factors, cell–cell contact, and cell–
matrix interactions (Discher et al.,
2009). One of the goals of bioma-
terial design in stem cell engineer-
ing is to control the differentiation
of these cells using substrate
properties (Table 2). However,
the ability to design novel materi-
als has been limited by a poor
understanding of the complex
signaling events that influence
cell differentiation (Fisher et al.,
2010). Furthermore, key compo-
nents involved in directing cell dif-
ferentiation often interplay and
change temporally and spatially.
In response to these dynamic and
complex changes in the microen-
vironment, stem cell responses to
the extracellular environment are
difficult to predict, and therefore,
contribute to contradictory results
in the literature.
The type and magnitude of
physical, chemical, and biological
cues can induce stem cell
differentiation into neurogenic,
osteogenic, chondrogenic, and
myogenic lineages, respectively.
Therefore, we will discuss how
these different types of cues that
can be designed into a biomaterial
can dictate stem cell differentia-
tion to specific cell lineages.
Neurogenic Differentiation
Recovery of neuronal networks
is limited by the inability of the
nervous system to self repair after
injury or trauma (Nisbet et al.,
2009). Among the polymeric bio-
materials, only a subset are suita-
ble for soft tissue engineering,
especially nerve regeneration,
owing to limitations in mechanical
properties such as stiffness (Gu
et al., 2010). Polymers with simi-
lar mechanical properties to the
native tissues they are targeted to
replace are preferred for tissue en-
gineering (Subramanian et al.,
2009). The stiffness of brain tissue
is 500 Pa (Saha et al., 2008).
Therefore, substrates with stiffness
in the range of 100 to 500 Pa are
ideal for neural tissue regeneration
(Engler et al., 2006; Saha et al.,
2008; Banerjee et al., 2009). For
example, PGA is relatively rigid and
not mechanically suitable for trans-
plantation into neural tissue
(Thonhoff et al., 2008).
Polymer hydrogels
An ideal biomaterial for neural
transplantation would have the
ability to be mixed with stem cells
and injected in a fluid form
(Thonhoff et al., 2008). It is bene-
ficial if the material is hydrophilic
and has a stiffness of 100 to 500
Pa (Gu et al., 2010). Meanwhile,
the porous network and intercon-
nectivity of the scaffold need to be
maintained in hydrated conditions,
to facilitate the transportation of
nutrients, oxygen, and metabo-
lites and tissue ingrowth. Hydro-
gels, as a class of polymeric mate-
rials, meet all of these require-
ments (Gu et al., 2010).
Hydrogels are soft, elastic,
water-swollen polymeric struc-
tures cross-linked either by cova-
lent bonds, physical cross-links
(e.g., entanglements), hydrogen
bonds, or strong van der Waals
interactions. Attention has been
given to these materials for neuro-
engineering because of their flexi-
bility in processing and handling.
One of the most common ways
to direct neurogenic differentiation
through hydrogels is to incorpo-
rate growth factors on peptide
sequences into the gel via either
simple mixing or covalent bonding
to the gel network. For example,
IKVAV, a peptide-derived from
laminin, and brain-derived neuro-
trophic factor (BDNF), reduce neu-
ronal death, induce neuronal dif-
ferentiation of hMSCs (Park et al.,
2010), and promote neuronal
regeneration in several models
(Tobias et al., 2001; Tuszynski
et al., 2003; Katz and Meiri, 2006).
Growth factors can also be deliv-
ered by genetically engineering
cells. An example of this strategy is
the engineering of fibroblasts to act
as a controlled delivery system to
continuously express the neurotro-
phic factors BDNF and NT-3
(Shanbhag et al., 2010). By utiliz-
ing this strategy, alginate con-
structs can serve as a microenvir-
onment for neural progenitor cell
(NPC) differentiation, representing
a promising bioengineered solution
for neural repair.
In the studies summarized
above, proneurogenic growth fac-
tors were immobilized on material
surfaces. Polymeric biomaterials
can also be used to release factors
for the purpose of blocking inhibi-
tors of tissue regeneration. For
example, Nogo-66 and NgR are
important receptors inhibiting
neuronal regeneration. Antibodies
(e.g., IgG) covalently attached to
biodegradable HA hydrogels have
been used to block the function of
Nogo-66 and NgR to treat brain
injury in rodents (Tian et al.,
2005). Although a sustained
release of IgG was observed, cell
culture experiments showed that
NSC differentiation on the same
HA substrates coated with the
same antibody was similar to that
on bare HA surfaces (Pan et al.,
2009). These results indicate that
cell–material interactions in vitro
may not be predictive of cell–ma-
terial interactions in vivo and that
neuronal tissue regeneration
requires further investigation.
TABLE 2. Properties of Polymeric Materials Controlling Stem Cell Differentiation
Physical properties Roughness, stiffness, topography, pore size, porosity, pore connectivity,
fiber diameter, fiber orientation, and surface charge
Chemical properties Composites, polymer concentration, density of crosslinker, hydrophobicity,
surface functionalization with peptides, functional groups,
adhesion molecules, and growth factors
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Besides being used as a delivery
vehicle for growth factors, several
properties of hydrogels can be
tuned to control cell differentiation.
For example, lower concentrations
(0.8–3%) of Matrigel support
migration of human NPCs and neu-
ronal differentiation. However,
when the concentration of Matrigel
increases to 50%, neurogenic dif-
ferentiation is inhibited (Katakowski
et al., 2005; Flanagan et al., 2006;
Thonhoff et al., 2008).
Another property of hydrogels
that affects lineage commitment
and cell differentiation is stiffness.
2D polymer substrates with moduli
ranging from 10 to 10,000 Pa affect
differentiation of adult NSCs (Saha
et al., 2008), with substrates hav-
ing moduli similar to brain tissue
(100–500 Pa), maximizing NSC dif-
ferentiation. Similarly, when NSCs
are encapsulated within 3D alginate
hydrogels, the greatest expression
of the neuronal marker b-tubulin III
is observed on the softest hydrogel
(Banerjee et al., 2009), indicating a
modulus value near that of brain
tissues best promotes neuronal dif-
ferentiation. The mechanisms by
which the mechanical properties of
hydrogels influence stem cell com-
mitment are not clear yet, but it
appears that cytoskeletal motors
may be involved in matrix-elasticity
sensing, which is responsible for
neuronal differentiation (Banerjee
et al., 2009; Discher et al., 2009).
Promotion of neural differentiation
on 2D and 3D biomaterials of lower
stiffness was confirmed by other
studies using other polymer sub-
strates such as polyacrylamide gels,
and alginate hydrogels (Engler
et al., 2006; Saha et al., 2008;
Wang et al., 2010b).
Nonhydrogel polymer
substrates
Nanoscale fibers favor neural
differentiation of both NSCs and
human ES cell-derived NPs com-
pared to microscale fibers (Yang
et al., 2005; Mahairaki et al.,
2011). The orientation and diame-
ter of polymer fibers also affect
neuronal differentiation. For
example, the degree of differentia-
tion of NPs is higher on aligned
nanopolycaprolactone and micro-
polycaprolactone fibers than on
random fibers and on 2D tissue
culture plate substrates (Mahairaki
et al., 2011). Differentiation of
NSCs on PLLA polymers, however,
is independent of fiber alignment
(Yang, 2005), suggesting that ma-
terial chemistry is a covariate with
stiffness in controlling differentia-
tion. The signaling pathways re-
sponsible for the effects of matrix
architecture on stem cell function
have yet to be elucidated, but it is
hypothesized that a lineage speci-
fication mechanism may involve
cytoskeletal and nuclear rearrange-
ments induced by the matrix archi-
tecture (Mahairaki et al., 2011).
Although a majority of studies
have focused on a direct control of
biochemical, physical, and me-
chanical cues on stem cell differen-
tiation, stem cell microenviron-
ments can also be manipulated
using conducting polymer scaffolds
(Lundin et al., 2011). The general
idea behind using conducting poly-
mers is that bulk properties (e.g.,
volume, conductivity and mechani-
cal properties) and surface proper-
ties (e.g., surface tension and
chemistry) dynamically change
when the redox states of the poly-
mer are reversibly switched
(Causley et al., 2005; Robinson
et al., 2006). For example, with
the conducting polymer PPy used
in neural tissue engineering, the
addition of anionic dopants of vary-
ing molecular weight and chemical
character: dodecylbenzenesulfo-
nate, TsO, ClO4, and Cl is hypothe-
sized to control cell differentiation.
PPy doped with the laminin peptide
sequence RNIAEIIKDI or nerve
growth factor enhances neuronal
differentiation of hESCs (Lee et al.,
2009b; Zhang et al., 2010a). Vari-
ous composites made of PPy and
other polymers such as PLGA also
enhance adhesion, proliferation,
and neurogenic differentiation of
stem cells (Lee et al., 2009a; Liu
et al. 2009, 2010a–d, 2011, Wei
et al. 2010).
Osteogenic Differentiation
Surface functionalization
Cell–matrix interactions condu-
cive to osteogenic differentiation
can be enhanced by surface func-
tionalization of polymers with dif-
ferent peptide sequences, growth,
or differentiation factors. Common
techniques of surface functionali-
zation include chemical modifica-
tions via cross-linking polymer
chains with bioactive factors,
physical modifications via physi-
sorption of the molecules onto the
surface, or physical entrapment
(Alvarez-Barreto et al., 2011).
One strategy to functionalize
biomaterials surfaces that has
received extensive study is the
tethering of RGD peptide sequen-
ces (Massia and Hubbell, 1991a;
Massia and Hubbell, 1991b;
Drumheller and Hubbell, 1994;
Hubbell, 1995; Hern and Hubbell,
1998; Kao et al., 2001; Vande-
Vondele et al., 2003; Fittkau
et al., 2005; Meinhart et al.,
2005; Gurav et al., 2007). This
peptide motif is found in many
bone ECM molecules, including fi-
bronectin, bone sialoprotein, and
osteopontin (Lee et al., 2007). The
positive role of RGD in cell adhe-
sion has been widely demon-
strated with various materials,
including glasses, hydroxyapatite,
and polymers (De Giglio et al.,
2000; Morgan et al., 2008;
Alvarez-Barreto et al., 2011). Sup-
port of osteogenic differentiation
by the presence of RGD is also
dose-dependent (Meinel et al.,
2004; Shin et al., 2005; Alvarez-
Barreto et al., 2011). Other pep-
tides and ligands such as the colla-
gen-mimetic peptide, GFOGER,
can accelerate and increase bone
formation, and improve osseointe-
gration of bone into an implant in
vivo (Reyes et al., 2007; Petrie
et al., 2008; Phillips et al., 2008;
Wojtowicz et al., 2010).
Although the majority of literature
focuses on a single surface function-
alization parameter (e.g., RGD con-
centration) on cell differentiation,
combining surface functionaliza-
tion with other parameters, such
as dynamic flow, can have a syn-
ergistic effect (Alvarez-Barreto
et al., 2011). For example, under
flow perfusion, which introduces
dynamic shear forces on cells,
RGD modification of PLLA scaffolds
has a more pronounced effect on
70 ZHANG AND KOHN
Birth Defects Research (Part C) 96:63–81, (2012)
the differentiation of MSCs. The
combined effects of flow perfusion
and RGD on differentiation are
also more prominent on titanium
(Holtorf et al., 2005). Another
interesting phenomenon is that
there is a critical RGD concentra-
tion that yields the greatest extent
of differentiation, and this optimal
concentration is dependent on the
flow rate. With increasing flow
rate, the optimal concentration of
RGD for cell differentiation
decreases (Alvarez-Barreto et al.,
2011). The dual roles of the integrin
receptor avb3 either in promoting
cell adhesion or inhibiting cell differ-
entiation explains the existence of
an optimal RGD concentration for
cell differentiation. Higher flow rate
can enhance the cell–matrix inter-
action, and therefore, increase the
inhibiting effect of receptor avb3.
Consequently, the optimal modifica-
tion level shifts to a lower concen-
tration.
Beside small peptide motifs, large
molecules, such as fibrin and hyal-
uronic acid that favor cell adhesion,
can be coated onto biomaterial
surfaces. However, these large mol-
ecules do not directly signal cells to
undergo osteogenic differentiation.
Instead, they create a suitable
environment for the activity of
inductive factors, such as bone
morphogenetic protein (BMP)-2
(Kang et al., 2011). For example,
the activity of alkaline phosphatase
in human ASCs cultured on fibrin
and hyaluronic acid modified scaf-
folds followed by BMP-2 loading
was significantly higher than that of
ASCs on scaffolds without BMP-2
or just BMP-2 supplemented cell
culture medium.
Composites
Many types of polymeric materi-
als have been investigated for
bone tissue engineering. Among
these materials, most attention
has focused on poly(a-hydroxy)
esters, such as PLA, PGA, and
PLGA (Cordonnier et al., 2011).
However, their biodegradability,
soluble factor release kinetics, me-
chanical properties, and process
ability differ depending on stereo-
chemistry and copolymer ratio
(Costa-Pinto et al., 2009; Aydin
et al., 2011). By combining poly-
mers with different properties, a
scaffold with a more desirable
combination of properties can be
obtained. One example would be
the matching of polymeric scaffold
degradation rate with that of in
situ host site healing by adjusting
the relative amount of PGA and
PLGA (Hutmacher, 2000). The
matching of rates minimizes
adverse reactions (e.g., inflamma-
tory) and is critical for the clinical
success of tissue engineered
substitutes. Other examples of
composites used in bone tissue
engineering are the mixture of nat-
urally derived materials, including
collagen, CS, and hyaluronic acid
containing specific ligands for
directing cell differentiation, with
synthetic polymers whose physical
properties are superior and more
easily controllable (Chen et al.,
2011).
It remains a challenge to separate
the various biomaterial parameters
that control stem cell differentiation.
To partially solve this problem,
hydrogels of PEG monomethacry-
late, poly(propylene glycol) mono-
methacrylate, and methacrylic algi-
nate (MA) have been developed
(Cha et al., 2011). In this system,
scaffold variables of charge density
and hydrophobicity are separately
controlled by controlling the mass
fractions of MA and PPGmM, and
porosity is controlled via lyophiliza-
tion, providing a versatile platform
enabling the independent control of
the matrix variables. An investiga-
tion of poly(N-isopropylacrylamide-
co-acrylic acid) hydrogel with inde-
pendently tuned matrix stiffness
and peptide concentration revealed
that these matrices induced bone
regeneration only when protease
degradable crosslinks were used to
create the network (Chung et al.,
2006). Similar systems with inde-
pendently tunable properties are
also used for systematic optimiza-
tion of material properties that lead
to enhanced cell adhesion, prolifera-
tion, and tissue regeneration
(Healy, 2004; Wall et al., 2010).
Bone is composed of an organic
and inorganic mineral matrix.
Therefore, it is also relevant to
make a composite material con-
sisting of both organic polymer
and inorganic bioactive ceramics,
such as tricalcium phosphate, hy-
droxyapatite, and bioactive
glasses. In fact, many in vitro and
in vivo studies have already dem-
onstrated that polymeric materials
containing ceramic second phases
or coated with ceramics exhibit at
least three improvements over
polymers: enhanced bioactivity,
better mechanical properties, and
structural integrity, and less
adverse host reactions after im-
plantation (Roether et al., 2002).
Ceramic materials such as bioac-
tive glasses can form a direct bond
to living bone tissue, while most
polymeric materials are usually
encapsulated by fibrous tissue in
vivo. Therefore, the incorporation
of a polymer with ceramic materi-
als can improve the bioactivity of
the scaffold. Adhesion proteins
also more easily adsorb to ceramic
surfaces (Zhao et al., 2006a),
resulting in increased cell adhe-
sion. Ceramic surfaces also induce
the formation of carbonated apa-
tite when placed in physiological
media. This calcium phosphate
layer plays an important role in
mediating cellular responses,
including cell differentiation
(Murphy et al., 2005). Another
advantage of ceramics is that the
dissolution products of bioactive
glasses and calcium silicate pro-
mote the expression of osteogenic
genes at a critical concentration of
Ca21 and/or Si (Xynos et al.,
2000a, b; Zhang et al., 2010b).
To make 3D polymer/ceramic
composites, ceramic particles are
infiltrated into porous polymeric
matrices by solid–liquid phase sep-
aration or electrophoretic deposi-
tion, or one component is coated on
the other using techniques such as
slurry-dipping technique or mineral
precipitation (Roether et al., 2002;
Zhao et al., 2006a). The former
way of synthesizing composites is
inspired by the hierarchical struc-
ture of bone, where calcium phos-
phate particles of a nano size are
embedded into an organic matrix.
However, organic/inorganic compo-
sites fabricated in this way often fail
to distribute the ceramic particles
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uniformly through the polymer
matrix. Therefore, the original
interconnected porous structure can
become blocked, and cell prolifera-
tion and differentiation are nega-
tively affected. In contrast, making
a composite material by coating
techniques can create a more uni-
form and reproducible ceramic layer
along the walls of pores, especially
if flow is used (Roether et al.,
2002; Segvich et al., 2008, 2009b),
making the output of cell differen-
tiation more controllable and pre-
dictable.
Chondrogenic Differentiation
To develop a stable and efficient
strategy for directing differentia-
tion of stem cells into a chondro-
genic lineage, various material
design approaches have been
investigated (Heymer et al., 2009;
Liu et al., 2010d; Anderson et al.,
2011; Lim et al., 2011; Park et al.,
2011b), including manipulating
polymeric properties, such as
macromer density, incoporating
growth and differentiation factors
into the polymeric substrate or
coating, immobilizing signaling
factors on the polymer surface,
and making polymer composites.
Substrate Properties
Some polymer substrates
intrinsically support and enhance
chondrogenic differentiation of
stem cells. One example is colla-
gen type II; compared to alginate
and collagen type I, collagen type
II promotes expression of the
chondrogenic genes sox9, collagen
type II, aggrecan, and COMP (Bos-
nakovski et al., 2006). The shape
of cells on type II collagen is also
more rounded compared to type I
collagen. Blocking the cell surface
receptor b1 integrin reduces chon-
drogenic gene expression and also
eliminates differences in Rock 1
and Rock 2 gene expression and
cell shape. Therefore, collagen
type II provides inductive signal-
ing for chondrogenic differentia-
tion by evoking a round cell shape
through the b1 integrin-mediated
Rho A/Rock signaling pathway (Lu
et al., 2010).
Dynamic loading can affect the
movement and distribution of
large molecules in dense hydro-
gels. Therefore, it is relevant to
investigate the effect of variations
in macromer density on chondro-
genesis. For example, chondro-
genesis and matrix formation are
proportional to macromer density
in methacrylated hyaluronic acid
hydrogels, due to a greater proba-
bility of receptor-mediated inter-
action with the high density mac-
romer material. However, a higher
macromer density yields function-
ally inferior constructs (Erickson
et al., 2009) due to lower perme-
ability of these construct, where
only limited matrix expansion by
cells occurs.
The majority of studies have
focused on the effect of mechani-
cal cues on cell differentiation
statically. However, an anionic
hydrogel system, PEG-chondroitin
sulfate (PEG/CS), undergoes re-
versible, anisotropic bending in an
electric field (Lim et al., 2011). By
using this unique property,
dynamic mechanical and electrical
cues can be simultaneously pro-
vided to cells. The magnitude of
mechanical cues can be tuned
through hydrogel crosslink den-
sity. More interestingly, the me-
chanical and electrical cues can be
independently varied, which allows
the investigation of one factor
while maintaining the other one
unchanged.
Growth factors
Chondrogenic differentiation of
stem cells can be induced by
growth factors and signaling mole-
cules, including transforming
growth factor-b (TGFb)-1, insulin-
like growth factor1 (IGF1), BMP2,
BMP7, growth and differentiation
factor5 (GDF5), glucosamine
(GLCN), dexamethasone, vitamin
C, and retinoic acid (Hwang et al.,
2006; Toh et al., 2010). The
induction effect of these factors is
dose, temporally, and spatially de-
pendent (Hwang et al., 2006;
Erisken et al., 2011). For example,
a 2-mM GlcN supplement in stand-
ard chondrogenic differentiation
medium increases levels of aggre-
can mRNA, and tissue-specific ECM
accumulation from ESC compared
to 0- and 10-mM concentrations
(Hwang et al., 2006). As an exam-
ple of the spatial effect of growth
factors, when human MSCs are
seeded on graded poly(e-caprolac-
tone) with concentration gradients
of two bioactive agents, insulin and
b-glycerophosphate (b-GP), chon-
drogenic differentiation is increased
at insulin-rich locations and osteo-
genic differentiation is increased at
b-GP-rich locations (Erisken et al.,
2011).
TGF-b1 also promotes chon-
drogenic differentiation. For exam-
ple, TGF-b1 can be encapsulated
with ASC into carrageenan-based
hydrogels to enhance chondro-
genic differentiation (RoCha et al.,
2011). A coupling of TGF-b1 with
bone marrow MSC macroaggre-
gates in a PLGA scaffold also
forms cartilaginous tissue (Liu
et al., 2010d). Another interesting
strategy of using TGF-b1 is to
incorporate growth factor-loaded
PLGA polymer microspheres within
hMSC aggregates themselves.
This approach promotes homoge-
neous cell differentiation across
the cell aggregates, which is not
usually seen in conventional cell
aggregate culture, since the induc-
tion effect is limited by the diffu-
sion of the chondrogenic growth
factor from the culture medium
into the aggregate and peripheral
cell layers.
The use of a single growth factor
may not provide all of the neces-
sary signals required for differen-
tiation (Mohan et al., 2010). A
combination of two or more induc-
tion factors can promote chondro-
genic differentiation of stem cells
more efficiently (Sharma et al.,
2007; Mohan et al., 2010; Toh
et al., 2010). The design of bioma-
terials systems to deliver combina-
tions of factors is motivated by the
in vivo milieu, where the formation
of a proper chondrogenic pheno-
type is regulated by the combined
action of multiple growth factors
spatially and temporally (Thorp
et al., 1992). Results from both in
vitro and in vivo experiments
show that a combination of TFGb-
3 and BMP2 (Mohan et al., 2010)
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or TGFb-3 and hyaluronic acid
(Sharma et al., 2007) promotes
more chondrogenic tissue forma-
tion than any of these factors indi-
vidually. The choice of factors and
sequence of delivery play impor-
tant roles in controlling chondro-
genic differentiation. For example,
TGF-b1 together with BMP7 yields
a more homogenous hyaline-like
cartilaginous tissue than a combi-
nation of TGF-b1 with IGF1, BMP2,
and GDF5 (Toh et al., 2010).
Composites
Similar to directing other stem
cell lineages, a combination of dif-
ferent polymeric materials can
provide appropriate mechanical
strength, biodegradability, bio-
compatibility, and surface charac-
teristics that promote cell adhe-
sion and chondrogenic differentia-
tion (Moutos et al., 2010; Ragetly
et al., 2010). For example, CS, a
natural biomaterial, which has
adequate mechanical properties
for supporting chondrogenesis
and cartilage formation, but lim-
ited cell adhesion ability, can be
coated with type II collagen to
increase cell adhesion and chon-
drogenic differentiation (Ragetly
et al., 2010). A thermosensitive
hydrogel, CS glycerol-phosphate
(CGP) lacks mechanical properties,
but the addition of starch to this
material improves its storage
modulus, and viscoelastic proper-
ties. Chondrogenic differentiation
of ASCs and cartilage matrix accu-
mulation can be increased on
starch incorporated CGP (Sa-Lima
et al., 2010).
Another approach to synthesiz-
ing composite scaffolds for carti-
lage regeneration is the fabrication
of biphasic or multiphasic scaffolds
made of a cartilage layer over a
subchondral bone region (Heymer
et al., 2009). This concept allows
the implementation of variations
in mechanical, structural, and
chemical properties in each layer
to mimic the natural structure of
osteochondral tissue (Heymer,
2009). In one example, a multi-
phasic composite scaffold contains
an upper collagen type I fiber
layer for articular cartilage repair,
separated by a hydrophobic inter-
face from a lower PLA for bone
repair. With TGFb-1, hMSCs secret
glycosaminoglycans and express
cartilage-specific markers aggrecan
and collagen type II. However, the
communication mechanisms
between the two distinct regions to
promote chondrogenesis in the
upper layer are not fully understood.
Using biphasic strategies, polymers
can be integrated with ceramic
materials such as hydroxyapatite, to
promote the simultaneous growth of
bone, cartilage, and a mineralized
interface tissue (Taboas et al.,
2003; Schek et al., 2004).
Surface functionalization
As previously discussed, growth
factors can be supplemented into
cell culture medium or encapsulated
into microsphere or bulk materials
to induce chondrogenic differentia-
tion of stem cells. Alternatively,
growth factors like TGF-b3 can be
immobilized on the polymer sur-
face. Surface immobilization leads
to more controllable spatial distribu-
tion, which avoids undesirable side
effects in the areas where no
growth factor is needed. Besides
better spatial control, biomaterial
surface engineering can also result
in sustained release and reduce the
consumption of growth factors in
comparison with simple addition of
factors to the media (Fan et al.,
2011). Among the various ways of
immobilizing growth factors, cova-
lent cross-linking can provide long-
term growth factor delivery, com-
pared to physical adsorption (Fan
et al., 2008; Fan et al., 2011).
Peptide sequences are often
tethered on biomaterial surfaces
to directly and indirectly affect cell
differentiation through receptor-
integrin interactions and other
mechanisms. Although the peptide
RGD is primarily known to facili-
tate cell adhesion, chondrogenic
differentiation of hMSCs has been
observed on RGD modified poly-
mer surfaces as well (Liu et al.,
2010c; Re’em et al., 2010; Stein-
metz and Bryant, 2011; You et al.,
2011). However, incorporation of
another peptide sequence, KLER,
with RGD can lead to more signifi-
cant type II collagen and aggrecan
gene expression and cartilage ECM
production. Because the KLER
sequence binds strongly to colla-
gen type II and is responsible for
matrix organization instead of
directly interacting with cell recep-
tors and activating a specific sig-
naling pathway, these results indi-
cate that an indirect cell-ECM
interaction is as important as
direct cell–material interactions in
controlling chondrogenic diferen-
tiation (Salinas and Anseth,
2010).
Functionalized polymeric surfa-
ces can also be used for gene
delivery to induce chondrogenic
differentiation. For example, poly-
ethylenimine (PEI) modified PLGA
nanoparticles are used to deliver
SOX5, SOX6, and SOX9 into
human MSCs to enhance chondro-
genesis. A surface functionaliza-
tion step is necessary for the
incorporation of DNA on these
materials, because neither PLGA
nor PEI can bind to DNA. The effi-
ciency of gene transfection follow-
ing surface functionalization
approach is sufficient to switch
chondrogenic differentiation of
stem cells (Park et al., 2011b).
Myogenic and Endothelial
Differentiation
Growth factors
Various growth factors can
affect the activity of either endo-
thelial cells or their progenitors,
including FGF, vascular endothelial
growth factor (VEGF), granulocyte
colony-stimulating factor, hepato-
cyte growth factor, and placental
growth factor (Beohar et al.,
2010). Utilization of these growth
factors can elicit proliferative and
angiogenic effects (Richardson
et al., 2001). However, delivery of
these factors from polymeric bio-
materials to induce cell differentia-
tion presents a challenge because
the cellular responses to these
soluble stimuli are dose-depend-
ent, temporally dependent, and
spatially dependent. Without
appropriate control of release
kinetics, these soluble factors may
negatively influence cell differen-
tiation (Beohar et al., 2010).
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Therefore, focus has been placed
on the design of ‘‘smart’’ materials
that can release soluble factors in
response to cellular needs or
changes in physiological condi-
tions. Growth factors can be
released when temperature, pH,
or even magnetic field changes
(Qiu and Park, 2001; Zhang et al.,
2004).
In addition to direct immobiliza-
tion of growth factors on polymer
surfaces, transplanted cells can
secrete growth factors that medi-
ate function of stem cells. For
example, transplanted cord blood
mononuclear cells (CBMNC)
seeded on a fibrin matrix were
used to treat myocardial infarction
in a rat model (Cho et al., 2007).
Transplanted human umbilical
cord blood cells have the ability to
produce various angiogenic growth
factors, including VEGF, bFGF, and
angiopoietin-1, which can induce
angiogenesis in vivo (Ma et al.,
2005; Yokoyama et al., 2006).
Combining CBMNC transplantation
and bFGF delivery can enhance
neovascularization in the ischemic
myocardium. It is also likely that
transplanted CBMNCs secrete
other angiogenic growth factors,
cytokines, and vasoactive factors
to enhance angiogenic efficacy,
which is also one of the advan-
tages of using biomaterials to
transplant cells compared to sup-
plementing individual growth fac-
tors (Cho et al., 2007).
3D composite scaffolds
Cardiac cells cultured in 3D not
only display distinct features that
are more representative of native
myocardium than cells in 2D cul-
ture (Clause et al., 2010), but also
show enhanced cell–cell interac-
tions, increased cardiac-specific
protein expression, spontaneous
beating cell activity, and contrac-
tility (Akins et al., 2007; Anderson
et al., 2007). However, there are
also limitations to 3D culturing.
The differentiation state of skeletal
muscle-derived stem cells in 3D
scaffolds is hard to define, due to
the coexistence of many cardiac
and skeletal muscle-specific pro-
teins produced by mature and
immature cells in the complex 3D
structure (Clause et al., 2010).
One important consideration in
3D scaffold design for cardiac
tissue engineering is that the scaf-
fold has to accommodate the con-
tractile function of differentiated
cardiomyocytes. Cardiomyocytes
embedded in a fibrin matrix lose
their contractile function and type
I collagen also limits the spontane-
ous contraction of cardiomyocytes
(Zimmermann et al., 2002;
Gonen-Wadmany et al., 2004;
Huang et al., 2007). Materials
such as PEGylated fibrinogen
hydrogels can retain the contract-
ile phenotype of cardiomyocytes
through the combined biological
and structural attributes of scaf-
fold, in which physical properties,
including biodegradation and com-
pliance, are controlled by the PEG,
while the fibrinogen confers bio-
logical activity (Shapira-Schweit-
zer et al., 2009).
Another class of materials that is
mechanically compatible with
heart muscle and avoids perma-
nent deformation and failure
under exposure to long-term cyclic
strain is elastomers. However, the
acidic degradation products of
some elastomers lead to an
inflammatory response and there-
fore can limit cell function. Incor-
poration of a lightly alkaline
second phase, such as 45S5
Bioglass1 particles, can buffer the
acidic cytotoxicity of degradation
products, and also improve the
functional activity of cardiomyo-
cytes (Chen et al., 2010).
Despite these positive results,
there is still limited information on
the use of physical stimuli to con-
trol stem cell differentiation into a
cardiac lineage. Biomaterial stiff-
ness can guide cardiac differentia-
tion of stem cells. For example, in
semi-interpenetrating polymer
networks made of collagen, fibro-
nectin and laminin, stiffness can
be controlled by controlling the
percentage of collagen. Stiffer
scaffolds resulting from higher col-
lagen concentrations inhibit endo-
thelial cell differentiation, possibly
because increasing the elastic
modulus decreases cell apoptosis
(Battista et al., 2005). These
results are consistent with other
studies (Kraehenbuehl et al.,
2008), where the stiffness of poly-
(ethyleneglycol) (PEG)-based extrac-
ellular matrices varies with the
number of cleavable crosslinker
matrix metalloproteinase-sensitive
peptides. On soft matrices, embry-
onal carcinoma (EC) cells express
more of the early cardiac tran-
scription factor, Nkx2.5, than its
control, embryoid bodies in sus-
pension. In contrast, stiffer matri-
ces decrease the number of
Nkx2.5-positive cells.
The range of surface stiffness
that induces optimal myogenesis
of stem cells is cell-dependent. In
the range of 10 to 17 kPa, myo-
genesis of hMSCs occurs maxi-
mally (Engler et al., 2006; Lanniel
et al., 2011). However, with
embryonal carcinoma cells a softer
matrix with a modulus of 0.3 kPa
enhances cardioprogenitor differ-
entiation more than a stiffer ma-
trix with a modulus of 4 kPa
(Kraehenbuehl et al., 2008). With
cardiosphere-derived cells, biode-
gradable poly(N-isopropylacryla-
mide) hydrogels having a modulus
of 30 kPa more significantly
upregulate cardiac expression
than gels with a modulus of 5 or
60 kPa (Li et al., 2011).
Besides structure and physical
properties, chemical composition
of a biomaterial can also be tuned
to affect cell myogenic differentia-
tion. When a scaffold is made of
collagen, fibronectin, and laminin,
the presence of fibronectin stimu-
lates endothelial cell differentiation
and vascularization. In contrast,
increasing the concentration of
laminin enhances cell differentia-
tion into beating cardomyocytes.
Because fibronectin and laminin
do not induce detectable matrix
mechanical and structural modifi-
cations, control of differentiation is
likely due to the cell adhesion
motifs present on these proteins
(Battista et al., 2005).
Surface modification
Peptide ligands can interact with
integrin receptors on cell surfaces,
mediating cell adhesion and a va-
riety of signaling pathways having
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essential biological consequences
for cardiac tissue engineering (Liu
et al., 2011). These peptides
include RGD, PGLD, and RGDSP
(Kraehenbuehl et al., 2008; Yu
et al., 2010; Moura and de
Queiroz, 2011). Surface modifica-
tions of polymeric scaffolds with
these peptide sequences can stim-
ulate the differentiation of cardiac
progenitor cells, promote cardiac
matrix maturation, and induce
angiogenesis in vitro. Despite
these promising in vitro data, in
vivo experiments show no signifi-
cant difference in angiogenesis
between RGD modified alginate
microbeads and unmodified ones
(Yu et al., 2010). These contradic-
tory results highlight that microen-
vironmental factors are different
between in vitro and in vivo situa-
tions, and conclusions drawn from
in vitro experiments on substrates
functionalized by peptides may not
be extrapolated to and be predic-
tive of in vivo function.
Besides peptide sequence, sur-
face functional groups can be
introduced into hydrogels through
plasma polymerization. These
functional groups include amino,
carboxylic, and phosphate groups.
Surfaces with carboxylic coatings
yield higher levels of expression of
the myogenic differentiation
marker MyoD1 than the other
functional groups (Lanniel et al.,
2011). The compatibility of car-
boxylic groups with directing car-
diac myocyte function was
observed in another study, where
an increased number of beating
cardiac myocytes was seen on the
carboxylic-functionalized surfaces
compared to hydroxylfunctional-
ized surfaces (Natarajan et al.,
2008). In spite of the ability to
control cardiomyocyte differentia-
tion by manipulating polymer sur-
face chemistry, the mechanisms
by which these surface functional
groups affect differentiation is not
clear.
It is important to note that the
stimulating effect of surface func-
tional groups on cardiac differen-
tiation can vary with other mate-
rial variables, such as stiffness.
For example, the addition of colla-
gen to a thermosensitive hydrogel
made of polycaprolactone, N-iso-
propylacrylamide, 2-hydroxyethyl
methacrylate, and dimethyl-c-bu-
tyrolactone acrylate has no effect
on the differentiation of cardio-
sphere-derived cells into a mature
cardiac lineage in low modulus
hydrogels of 5 kPa, but enhances
expression of the cardiac genes
MYH6 and cTnT in medium modu-
lus hydrogels of 30 kPa (Li et al.,
2011). However, carboxylic groups
on polyacrylamide hydrogels
enhance MyoD1 expression by
human MSCs on low modulus
surfaces of 10 kPa, compared to
a lower levels of MyoD1 expres-
sion on high modulus surfaces of
 80 kPa (Lanniel et al., 2011).
SUMMARY AND FUTURE
DIRECTIONS
In summary, various factors from
the extracellular environment
known to control cell adhesion,
proliferation, and differentiation
have been incorporated into the
design of biomaterials to achieve
the objective of creating increased
communication between biomate-
rials and their surrounding biologi-
cal environment. The effects of
these material modifications on
cell activity are dose-dependent,
temporally dependent, and spa-
tially dependent. Biomaterials
design and synthesis, as well as
other tissue engineering strategies
are used to create a controlled
microenvironment and mimic the
dose-response relations in time
and space to favor specific types
of cell activity.
Despite the interesting in vitro
and in vivo results summarized in
this review, the precise control of
cell activity by polymeric sub-
strates still represents a major
challenge due to complex and
dynamic interactions in these mul-
ticomponent systems, involving
many biological, physical, and
chemical processes. For instance,
investigations of how polymer
stiffness affects cell activity do not
account for changes in stiffness in
situ over time, as cells lay down
ECM to create a ‘‘new’’ substrate.
When investigating peptide immo-
bilization on polymer surfaces, the
distribution of peptide sequences
on the surface and how distribu-
tion patterns affect cell activity
need to be accounted for. There-
fore, to gain better understanding
of cell–biomaterial interactions, a
systematic study that evaluates
the role of extracellular factors in
a time-dependent manner is
required, even if the study is sim-
plified by investigating only one
factor. As new methods and strat-
egies become available to fabri-
cate new polymeric substrates
with independently controllable
properties, and new techniques
are able to offer more precise
monitoring and characterization of
substrate properties and cell activ-
ities, better understanding of cell–
biomaterial interactions can be
achieved in the future. Ultimately,
better control of cell–biomaterial
interactions will enable advances in
tissue engineering to be achieved.
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